Ocular infection with herpes simplex virus type 1: prevention of acute herpetic encephalitis by systemic administration of virus-specific antibody.
about
Antibody protects against lethal infection with the neurally spreading reovirus type 3 (Dearing)Lymphocyte reactivity contributes to protection conferred by specific antibody passively transferred to herpes simplex virus-infected mice.Ontogeny of murine cellular cytotoxicity to herpes simplex virus-infected cells.Sodium lauryl sulfate increases the efficacy of a topical formulation of foscarnet against herpes simplex virus type 1 cutaneous lesions in mice.Efficacies of gel formulations containing foscarnet, alone or combined with sodium lauryl sulfate, against establishment and reactivation of latent herpes simplex virus type 1Protection against lethal challenge of BALB/c mice by passive transfer of monoclonal antibodies to five glycoproteins of herpes simplex virus type 2.Use of monoclonal antibodies for analysis of antibody-dependent immunity to ocular herpes simplex virus type 1 infection.Antibody inhibits defined stages in the pathogenesis of reovirus serotype 3 infection of the central nervous system.Immune responses to labial infection of BALB/c mice with herpes simplex virus type 1.Role of Fc fragments in antibody-mediated recovery from ocular and subcutaneous herpes simplex virus infections.Herpes simplex virus type 1 mutant strain in1814 establishes a unique, slowly progressing infection in SCID mice.Passive immune protection by herpes simplex virus-specific monoclonal antibodies and monoclonal antibody-resistant mutants altered in pathogenicityImmunogenicity of herpes simplex virus glycoproteins gC and gB and their role in protective immunity.Monoclonal antibodies suppress replication of herpes simplex virus type 1 in trigeminal ganglia.Maternal Antiviral Immunoglobulin Accumulates in Neural Tissue of Neonates To Prevent HSV Neurological Disease.Pathogenesis and immunobiology of herpes simplex virus in mouse and man.Addition of a C-terminal cysteine improves the anti-herpes simplex virus activity of a peptide containing the human immunodeficiency virus type 1 TAT protein transduction domain.Protective effects of anti-glycoprotein D monoclonal antibodies in murine herpetic keratitis.An improved model of recurrent herpetic eye disease in mice.Protection from retinal necrosis by passive transfer of monoclonal antibody specific for herpes simplex virus glycoprotein D.Efficacy of herpes vaccine and acyclovir (ACV) in a rabbit model following intraocular inoculation of herpes simplex virus.Mechanism of antibody-mediated protection against herpes simplex virus infection in athymic nude mice: requirement of Fc portion of antibody.Antibody mediated destruction of keratocytes infected with herpes simplex virus.The influence of different modes of immunization on the experimental genital herpes simplex virus infection of mice.Protectivity of herpes simplex virus antigens: studies in mice on the adjuvant effect of PICLC and on the dependence of protection on T cell competence.Pathogenesis of genital herpes simplex virus infection in mice. IV. Quantitative aspects of viral latency.Observations on recovery from and recurrence of HSV-2 infections in adult mice that were rescued from lethal vaginal infection by antiviral therapy.Quantitation of purified monoclonal antibody needed to prevent HSV-1 induced stromal keratitis in mice.
P2860
Q27486833-49A7C69D-BAC2-4700-A113-D13349F30F3AQ33906859-53DE3662-DABC-474A-BC5F-69586DFEB19DQ33911628-DD9BB2B1-1B90-4154-8180-6F34BE3A6B43Q33980379-C678CE41-AE46-4738-8DED-391C63F57C97Q33981823-6E660E33-CE25-4F47-B35A-9819BFE30A4DQ36333640-D623C81B-7B84-4F34-92C4-26BDAB19190DQ36335255-D9C065FD-C32B-4952-8660-857585E49FCAQ36356774-2B1810CF-BAC6-4D51-90E4-F5D2796F78AFQ36422499-9B542538-4643-4134-A392-A676AAE5D13FQ36423892-C2BBE1AE-353E-492B-94B7-0FE9E0CA34E5Q36687316-58E24017-8D6D-4E8C-8928-388D56153925Q36854824-24C95B96-639E-401F-AE32-6394F757A813Q36917531-C47EE98E-2C5A-4DB4-A88A-C012F933BA9BQ36918805-CD126DCA-A5B9-4098-AC16-A480F9E2E9BAQ38692329-10898546-85BB-4B30-BCC6-1675B771C522Q39614014-FE663962-93C8-4D0F-A7D2-9765B44DD30DQ42138358-B694F1B1-6528-4712-8A69-1FF5A2DC9BAFQ44298487-DACBF484-BA95-4C45-8312-385D3F10DB8DQ44363606-64CCB0D8-9BDC-4EEB-BC9C-3E531532759AQ44687189-21FB020D-D827-4FB1-A45C-543055F0DFA2Q45788760-625E4738-8A4B-4A45-8760-E2AD02AC3798Q45799569-6F6202A8-F1DB-427D-9F33-B4E1AEA4BC08Q45800981-C3A3DCDC-76BB-4162-9BB5-C05F57C5C986Q45801486-C38989A5-5977-4700-BCA5-4AA7BBB4C513Q45801490-DC85EFAA-9AB5-4BC8-AE2C-5489A0321737Q45836025-192D2230-FF28-421F-84DC-FAA7B81112F8Q46433522-B9B38D6B-0D8D-42B2-B9A3-AFD5AE758D55Q54354126-13F518BA-5D14-4A5F-9547-36CA3F2C6DAA
P2860
Ocular infection with herpes simplex virus type 1: prevention of acute herpetic encephalitis by systemic administration of virus-specific antibody.
description
1979 nî lūn-bûn
@nan
1979年の論文
@ja
1979年論文
@yue
1979年論文
@zh-hant
1979年論文
@zh-hk
1979年論文
@zh-mo
1979年論文
@zh-tw
1979年论文
@wuu
1979年论文
@zh
1979年论文
@zh-cn
name
Ocular infection with herpes s ...... on of virus-specific antibody.
@en
type
label
Ocular infection with herpes s ...... on of virus-specific antibody.
@en
prefLabel
Ocular infection with herpes s ...... on of virus-specific antibody.
@en
P2093
P356
P1476
Ocular infection with herpes s ...... on of virus-specific antibody.
@en
P2093
P304
P356
10.1093/INFDIS/140.4.534
P407
P577
1979-10-01T00:00:00Z